#59 M2GEN's Platform For More Accurate and Faster Oncology Clinical Trial Recruitment

In this epsisode of BioTech IQ Ammon interviews the Chief Growth Officer of M2GEN Todd Johnson, MD. M2GEN partners with 18 of the nation’s leading cancer centers, through the Oncology Research Information Exchange Network® (ORIEN), to deliver oncology informatics-based solutions to accelerate therapy discovery, development and delivery of precision medicine. M2GEN is one of the only companies to ensure that patient data has been granted through consent.M2GEN utilizes the IRB-approved protocol, Total Cancer Care®, that allows for enhanced patient engagement through the ability to re-contact patients and facilitates linkages across disparate sources of data, creating a research ecosystem which can significantly benefit patients and improve patient care. Listen to more interviews at thebiotechiqpodcast.comDan Sfera's interview with Ammon https://youtu.be/86MtcfBnUmgSupport the showCheck me out on LinkedIn https://www.linkedin.com/in/ammonr/